Viteva  Home logo
Supplement Safety

 Untitled 1
Melatonin Research

 Prolonged-release melatonin for the treatment of insomnia in patients over 55 years.

Melatonin to prevent migraine or tension-type headache in children.

Melatonin improves memory acquisition under stress independent of stress hormone release.

Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease.

The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study).

The role of melatonin in the immuno-neuro-psychology of mental disorders.

Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Melatonin: a hormone that modulates pain.

Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study.

Melatonin and its relevance to jet lag.

Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis.

Preoperative melatonin and its effects on induction and emergence in children undergoing anesthesia and surgery.

Melatonin as a potential therapeutic agent in psychiatric illness.

[The effect of melatonin on oxidative DNA damage in gastric mucosa cells of patients with functional dyspepsia]

Therapeutic potential of melatonin in traumatic central nervous system injury.

The circadian melatonin rhythm and its modulation: possible impact on hypertension.
 Untitled 1
   Home    Terms of Use    Privacy
Home    Research    Terms of Use    Privacy Policy    Advertise    Newsletter    About Us    Contact Us
Copyright ©2009 Viteva